# Study of Intraperitoneal Carboplatin With IV Paclitaxel and Bevacizumab in Untreated Ovarian Cancer

> **NCT01220154** · PHASE1 · COMPLETED · sponsor: **David O'Malley** · enrollment: 9 (actual)

## Conditions studied

- Ovarian Cancer
- Fallopian Tube Cancer
- Primary Peritoneal Cancer
- No Prior Chemotherapy

## Interventions

- **DRUG:** Paclitaxel
- **DRUG:** Carboplatin
- **DRUG:** Bevacizumab

## Key facts

- **NCT ID:** NCT01220154
- **Lead sponsor:** David O'Malley
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04-28
- **Primary completion:** 2023-07-17
- **Final completion:** 2023-07-17
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2025-02-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01220154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01220154, "Study of Intraperitoneal Carboplatin With IV Paclitaxel and Bevacizumab in Untreated Ovarian Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01220154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*